Kaloyannidis P - Search Results

1

Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation.

Papaioannou G, Batsis I, Iordanidis F, Vadikoliou C, Kaloyannidis P, Anagnostopoulos A, Athanasiadou A. Papaioannou G, et al. Among authors: kaloyannidis p. Hematol Oncol. 2011 Sep;29(3):161-3. doi: 10.1002/hon.979. Epub 2010 Dec 20. Hematol Oncol. 2011. PMID: 21922511 No abstract available.

2

G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

Yannaki E, Athanasiou E, Xagorari A, Constantinou V, Batsis I, Kaloyannidis P, Proya E, Anagnostopoulos A, Fassas A. Yannaki E, et al. Among authors: kaloyannidis p. Exp Hematol. 2005 Jan;33(1):108-19. doi: 10.1016/j.exphem.2004.09.005. Exp Hematol. 2005. PMID: 15661404 Free article.

3

AntiCD30-Conjugated Antibody Plus Standard BEAM as Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Systemic Anaplastic Large Cell Lymphoma.

Kaloyannidis P, Al-Charfli B, George B, Khalil C, Al-Moghrabi N, Mustafa S, Ibrahim D, Alfar M, Ibrahim F, Odeh B, Daryahya M, Shabo P. Kaloyannidis P, et al. Hematol Rep. 2025 Jan 20;17(1):3. doi: 10.3390/hematolrep17010003. Hematol Rep. 2025. PMID: 39846607 Free PMC article.

4

Paving the Road for Haematopoietic Stem Cell Transplantation in the United Arab Emirates: A Single Centre's Experience.

Kaloyannidis P, George B, Alrustamani A, Khalil C, Al-Charfli B, Al-Moghrabi N, Ibrahim D, Alfar M, Daryahya M, Mheidly K, El-Saddik A, Al-Shamsi HO. Kaloyannidis P, et al. J Blood Med. 2024 Nov 4;15:471-475. doi: 10.2147/JBM.S468665. eCollection 2024. J Blood Med. 2024. PMID: 39524018 Free PMC article.

5

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease.

Gavriilaki E, Papchianou E, Karavalakis G, Batsis I, Panteliadou A, Lazaridou A, Mallouri D, Constantinou V, Karvouni P, Evangelidis P, Papakonstantinou A, Papalexandri A, Kaloyannidis P, Spyridis N, Bousiou Z, Vardi A, Yannaki E, Sotiropoulos D, Sakellari I. Gavriilaki E, et al. Among authors: kaloyannidis p. Pharmaceuticals (Basel). 2024 Sep 27;17(10):1279. doi: 10.3390/ph17101279. Pharmaceuticals (Basel). 2024. PMID: 39458920 Free PMC article.

6

Brentuximab vedotin plus bendamustine versus platinum-based regimens as 1st salvage therapy and 'bridge' to autologous hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma.

Kaloyannidis P, Al Zayer M, Al Darweesh M, Al Batran M, Al Garni A, Al Naim A, Al Hashmi H, Kanfar S. Kaloyannidis P, et al. Leuk Lymphoma. 2023 Mar;64(3):742-745. doi: 10.1080/10428194.2022.2164195. Epub 2023 Jan 11. Leuk Lymphoma. 2023. PMID: 36628991 No abstract available.

7

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??

Kaloyannidis P, Abdulla F, Mutahar E, Al Hashim H, Al Harbi S, Estanislao A, Al Hashmi H. Kaloyannidis P, et al. J Blood Med. 2022 Oct 25;13:619-630. doi: 10.2147/JBM.S380133. eCollection 2022. J Blood Med. 2022. PMID: 36317167 Free PMC article.

8

Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge.

Al-Shamsi HO, Abyad A, Kaloyannidis P, El-Saddik A, Alrustamani A, Abu Gheida I, Ziade A, Dreier NW, Ul-Haq U, Joshua TLA, El Kinge AR, Coelho R, Ibrahim D, Afrit M, Al-Lababidi B, Aabideen Z, Sabhani M, Shah R, Makhlouf G, Iskandaerani L, Iqbal F, Narayanan S, Ameen M, Morrison T, Khalil C, Mheidly K. Al-Shamsi HO, et al. Among authors: kaloyannidis p. Clin Pract. 2022 Jan 28;12(1):84-90. doi: 10.3390/clinpract12010010. Clin Pract. 2022. PMID: 35200262 Free PMC article. Review.

9

Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?

Kaloyannidis P, Apostolidis J. Kaloyannidis P, et al. Curr Treat Options Oncol. 2021 Jun 10;22(8):65. doi: 10.1007/s11864-021-00864-x. Curr Treat Options Oncol. 2021. PMID: 34110512 Review.

10

Non-transplantable cord blood units as a source for adoptive immunotherapy of leukaemia and a paradigm of circular economy in medicine.

Koukoulias K, Papadopoulou A, Kouimtzidis A, Papayanni PG, Papaloizou A, Sotiropoulos D, Yiangou M, Costeas P, Anagnostopoulos A, Yannaki E, Kaloyannidis P. Koukoulias K, et al. Among authors: kaloyannidis p. Br J Haematol. 2021 Jul;194(1):158-167. doi: 10.1111/bjh.17464. Epub 2021 May 26. Br J Haematol. 2021. PMID: 34036576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters